You May be Eligible to Receive up to $800,000 in Compensation!
Investigations Indicate that both Enfamil and Similac Infant Formulas May Be Blamed for NEC in Babies.
Necrotizing enterocolitis (NEC) causes inflammation leading to intestinal tissue damage and tissue death. NEC is the most common cause of death in hospitalized premature infants more than 2 weeks old.
Mead Johnson & Company, LLC and Abbott Laboratories (the makers of Enfamil and Similac) are being accused of using cow’s milk-based formula products that can cause premature infants to develop life-threatening necrotizing enterocolitis (NEC).
It is now established scientific fact that “Premature infants fed formula are more likely to develop necrotizing enterocolitis (NEC) than those who are breastfed.” Despite this knowledge, the companies behind these popular baby formula products have done nothing to warn new parents – and medical professionals – about these dangers
If your child was fed Similac or Enfamil in the NICU, you may qualify for up to $800,000 in compensation.
Payments may be increased or decreased on a pro rata basis.
The information provided on this website does not, and is not intended to, constitute legal advice; instead, all information, content, and materials available on this site are for general informational purposes only. Information on this website may not constitute the most up-to-date legal or other information. This website contains links to other third-party websites. Such links are only for the convenience of the reader, user or browser; the ABA and its members do not recommend or endorse the contents of the third-party sites. Readers of this website should contact their attorney to obtain advice with respect to any particular legal matter. No reader, user, or browser of this site should act or refrain from acting on the basis of information on this site without first seeking legal advice from counsel in the relevant jurisdiction. Only your individual attorney can provide assurances that the information contained herein – and your interpretation of it – is applicable or appropriate to your particular situation.
Use of, and access to, this website or any of the links or resources contained within the site do not create an attorney-client relationship between the reader, user, or browser and website authors, contributors, contributing law firms, or committee members and their respective employers. Settlement Research Inc. is not a law firm and does not directly provide legal advice. We do not recommend or endorse any attorneys that pay to participate. The views expressed at, or through, this site are those of the individual authors writing in their individual capacities only – not those of their respective employers, the ABA, or committee/task force as a whole. All liability with respect to actions taken or not taken based on the contents of this site are hereby expressly disclaimed. Form submission does not guarantee compensation. The content on this posting is provided “as is;” no representations are made that the content is error-free.